Skip to main content
logo
Evogene Ltd. (TLV:EVGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
410.90
-9.70 (-2.31%)
Sep 11, 2025, 5:24 PM IDT

Evogene Revenue

Evogene had revenue of $884.00K USD in the quarter ending June 30, 2025, a decrease of -3.28%. This brings the company's revenue in the last twelve months to $9.44M, down -0.05% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.

Revenue (ttm)
$9.44M
Revenue Growth
-0.05%
P/S Ratio
1.15
Revenue / Employee
$80.72K
Employees
117
Market Cap
36.70M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.51M2.87M50.90%
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Teva Pharmaceutical Industries56.02B
Danel (Adir Yeoshua)2.84B
Kamada571.15M
BrainsWay155.27M
SofWave Medical234.12M
Bait Bakfar106.25M
Novolog (Pharm-Up 1966)2.04B
Ilex Medical922.54M
Revenue Rankings

Evogene News

More News